Application of Disulfiram and its Metabolites in Treatment of Inflammatory Disorders

Disulfiram has been used clinically for decades as an anti-alcoholic drug. Recently, several studies have demonstrated the anti-inflammatory effects of disulfiram and its metabolism, which can alleviate the progression of inflammation in vivo and in vitro. In the current study, we summarize the anti...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenyi Guo (Author), Shihong Chen (Author), Chengqing Li (Author), Jianwei Xu (Author), Lei Wang (Author)
Format: Book
Published: Frontiers Media S.A., 2022-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_dacd30c018014d88b8e76b2b9df1b67f
042 |a dc 
100 1 0 |a Wenyi Guo  |e author 
700 1 0 |a Shihong Chen  |e author 
700 1 0 |a Chengqing Li  |e author 
700 1 0 |a Jianwei Xu  |e author 
700 1 0 |a Lei Wang  |e author 
245 0 0 |a Application of Disulfiram and its Metabolites in Treatment of Inflammatory Disorders 
260 |b Frontiers Media S.A.,   |c 2022-02-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2021.795078 
520 |a Disulfiram has been used clinically for decades as an anti-alcoholic drug. Recently, several studies have demonstrated the anti-inflammatory effects of disulfiram and its metabolism, which can alleviate the progression of inflammation in vivo and in vitro. In the current study, we summarize the anti-inflammatory mechanisms of disulfiram and its metabolism, including inhibition of pyroptosis by either covalently modifying gasdermin D or inactivating nod-like receptor protein 3 inflammasome, dual effects of intracellular reactive oxygen species production, and inhibition of angiogenesis. Furthermore, we review the potential application of disulfiram and its metabolism in treatment of inflammatory disorders, such as inflammatory bowel disease, inflammatory injury of kidney and liver, type 2 diabetes mellitus, sepsis, uveitis, and osteoarthritis. 
546 |a EN 
690 |a disulfiram 
690 |a inflammation 
690 |a pyroptosis 
690 |a NLRP3 
690 |a GSDMD 
690 |a ROS 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 12 (2022) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2021.795078/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/dacd30c018014d88b8e76b2b9df1b67f  |z Connect to this object online.